We previously identified a second-messenger-regulated signaling system in the environmental bacterium Pseudomonas fluorescens which controls biofilm formation in response to levels of environmental inorganic phosphate. This system contains the transmembrane cyclic di-GMP (c-di-GMP) receptor LapD and the periplasmic protease LapG. LapD regulates LapG and controls the ability of this protease to process a large cell surface adhesin protein, LapA. While LapDG orthologs can be identified in diverse bacteria, predictions of LapG substrates are sparse. Notably, the opportunistic pathogen Pseudomonas aeruginosa harbors LapDG orthologs, but neither the substrate of LapG nor any associated secretion machinery has been identified to date. Here, we identified P. aeruginosa CdrA, a protein known to mediate cell-cell aggregation and biofilm maturation, as a substrate of LapG. We also demonstrated LapDG to be a minimal system sufficient to control CdrA localization in response to changes in the intracellular concentration of c-di-GMP. Our work establishes this biofilm signaling node as a regulator of a type Vb secretion system substrate in a clinically important pathogen.
IMPORTANCEHere, the biological relevance of a conserved yet orphan signaling system in the opportunistic pathogen Pseudomonas aeruginosa is revealed. In particular, we identified the adhesin CdrA, the cargo of a two-partner secretion system, as a substrate of a periplasmic protease whose activity is controlled by intracellular c-di-GMP levels and a corresponding transmembrane receptor via an inside-out signaling mechanism. The data indicate a posttranslational control mechanism of CdrA via c-di-GMP, in addition to its established transcriptional regulation via the same second messenger.
Bacteria in nature exist as free-swimming motile organisms or as sessile communities adhered to solid surfaces that are enveloped in a self-produced matrix of adhesive proteins, polysaccharides, and nucleic acids (1). These biofilms protect bacterial communities from their surrounding environment, and as a result, infections caused by biofilm-forming pathogens are often tolerant to traditional antibiotic therapies and the immune system. Understanding the molecular mechanisms governing the regulation of bacterial biofilm formation is thus paramount to finding new avenues for treating such chronic infections.Biofilm formation is regulated via a bacterial second messenger, cyclic di-GMP (c-di-GMP), enzymes for its biosynthesis and degradation, and binding proteins that monitor levels of this cyclic dinucleotide. High levels of c-di-GMP are often associated with a switch to a sessile lifestyle through the binding of the second messenger to receptor proteins (2). Our previous studies identified a central c-di-GMP-specific receptor, LapD, and its associated signaling system in the environmental bacterium and model system for biofilm formation Pseudomonas fluorescens (3-6) (Fig. 1A). In particular, we found that the inner membrane-localized LapD receptor is autoinhibited at...